Literature DB >> 23637473

Evolution of HIV-1 in India.

Pradeep Seth1.   

Abstract

Nearly 25 years after the discovery of the human immunodeficiency virus type 1 (HIV-1) effective control of the AIDS pandemic remains elusive. At the root of this challenge is the evolution of this virus to elude immune control. Error-prone nature of replication and retro-transcription is the hallmark of this virus. This fidelity of replication in HIV-1 is due to the absence of proof-reading/repair and post-replicative error correction mechanisms that normally operate during replication of DNA viruses. Advances in sequencing technology and expanded disease surveillance have allowed researchers to characterize the variation in HIV-1 around the world and within individual patient overtime. Although HIV-1 has been classified into distinct subtypes, the classification does not reflect dynamic genetic evolution of HIV-1 through which new strains are constantly emerging. The resultant viral diversity has implications for differential rates of disease progression in different geographical areas, differential responses to antiretroviral therapy (including the development of resistance), and vaccine development. In this review evolution of HIV-1 in India is discussed.

Entities:  

Keywords:  Evolution; HIV; HIV-1 diversity; HIV-1 subtype C; HIV-1 subtypes; Phylogenetic analysis

Year:  2010        PMID: 23637473      PMCID: PMC3550774          DOI: 10.1007/s13337-010-0001-4

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  28 in total

1.  Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation.

Authors:  F Gao; N Vidal; Y Li; S A Trask; Y Chen; L G Kostrikis; D D Ho; J Kim; M D Oh; K Choe; M Salminen; D L Robertson; G M Shaw; B H Hahn; M Peeters
Journal:  AIDS Res Hum Retroviruses       Date:  2001-05-20       Impact factor: 2.205

2.  HIV type 1 subtypes circulating in eastern and northeastern regions of India.

Authors:  Dibyakanti Mandal; S Jana; S K Bhattacharya; Sekhar Chakrabarti
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-01       Impact factor: 2.205

3.  Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India.

Authors:  Nagadenahalli Byrareddy Siddappa; Prashanta Kumar Dash; Anita Mahadevan; Anita Desai; Narayana Jayasuryan; Vasanthapuram Ravi; Parthasarathy Satishchandra; Susarla K Shankar; Udaykumar Ranga
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

4.  Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C.

Authors:  M O Salminen; B Johansson; A Sönnerborg; S Ayehunie; D Gotte; P Leinikki; D S Burke; F E McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  1996-09-20       Impact factor: 2.205

5.  HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate.

Authors:  U Dietrich; M Grez; H von Briesen; B Panhans; M Geissendörfer; H Kühnel; J Maniar; G Mahambre; W B Becker; M L Becker
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

6.  Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

Authors:  Grace P McCormack; Judith R Glynn; Amelia C Crampin; Felix Sibande; Dominic Mulawa; Lyn Bliss; Philip Broadbent; Katia Abarca; Jorg M Pönnighaus; Paul E M Fine; Jonathan P Clewley
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network.

Authors:  E Couturier; F Damond; P Roques; H Fleury; F Barin; J B Brunet; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

View more
  5 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.

Authors:  Austin Huang; Joseph W Hogan; Sorin Istrail; Allison Delong; David A Katzenstein; Rami Kantor
Journal:  Future Virol       Date:  2012-05       Impact factor: 1.831

3.  Trends of subtype variation of human immunodeficiency virus type 1 in Zhejiang Province, China.

Authors:  Yaping Yao; Ruolei Xin; Jiezhe Yang; Yun Xu; Jiafeng Zhang; Yan Xia; Xiaohong Pan; Zhihong Guo; Yanhui Song
Journal:  Virus Genes       Date:  2014-11-20       Impact factor: 2.332

4.  Understanding of HIV/AIDS in the international border area, Manipur: Northeast India.

Authors:  A L Sharma; T R Singh; L S Singh
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

5.  Immunological markers for identifying recent HIV infection in North-West India.

Authors:  Chandar Kanta Chauhan; P V M Lakshmi; Vivek Sagar; Aman Sharma; Sunil K Arora; Rajesh Kumar
Journal:  Indian J Med Res       Date:  2020-09       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.